{
  "N/R/U": null,
  "Applicant": "Ablynx NV",
  "BLA Number": "761112",
  "Proprietary Name": "Cablivi",
  "Proper Name": "caplacizumab-yhdp",
  "BLA Type": "351(a)",
  "Strength": "11MG",
  "Dosage Form": "For injection",
  "Route of Administration": "Intravenous, Subcutaneous ",
  "Product Presentation": "Single-Dose Vial",
  "Marketing Status": "Rx",
  "Licensure": "Licensed",
  "Approval Date": "6-Feb-19",
  "Ref. Product Proper Name": null,
  "Ref. Product Proprietary Name": null,
  "Supplement Number": null,
  "Submission Type": "Original",
  "License Number": "2085",
  "Product Number": "1",
  "Center": "CDER",
  "Date of First Licensure": null,
  "Exclusivity Expiration Date": null,
  "First Interchangeable Exclusivity Exp. Date": null,
  "Ref. Product Exclusivity Exp. Date": null,
  "Orphan Exclusivity Exp. Date": "6-Feb-26"
}